Weybosset Research & Management LLC held its position in CVS Health Corporation (NYSE:CVS) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,985 shares of the pharmacy operator’s stock at the close of the second quarter. Weybosset Research & Management LLC’s holdings in CVS Health Corporation were worth $321,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Foster & Motley Inc. raised its holdings in shares of CVS Health Corporation by 7.4% in the second quarter. Foster & Motley Inc. now owns 13,488 shares of the pharmacy operator’s stock valued at $1,085,000 after purchasing an additional 925 shares during the last quarter. Enterprise Financial Services Corp raised its holdings in shares of CVS Health Corporation by 4.9% in the second quarter. Enterprise Financial Services Corp now owns 3,890 shares of the pharmacy operator’s stock valued at $313,000 after purchasing an additional 183 shares during the last quarter. Parsec Financial Management Inc. raised its holdings in shares of CVS Health Corporation by 2.6% in the second quarter. Parsec Financial Management Inc. now owns 281,237 shares of the pharmacy operator’s stock valued at $22,628,000 after purchasing an additional 7,097 shares during the last quarter. Markel Corp raised its holdings in shares of CVS Health Corporation by 1.1% in the second quarter. Markel Corp now owns 267,000 shares of the pharmacy operator’s stock valued at $21,483,000 after purchasing an additional 3,000 shares during the last quarter. Finally, K.J. Harrison & Partners Inc raised its holdings in shares of CVS Health Corporation by 11.0% in the second quarter. K.J. Harrison & Partners Inc now owns 60,255 shares of the pharmacy operator’s stock valued at $4,848,000 after purchasing an additional 5,964 shares during the last quarter. 81.49% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Corporation (NYSE CVS) opened at 76.92 on Friday. The stock has a 50 day moving average of $79.64 and a 200 day moving average of $79.03. The stock has a market cap of $78.19 billion, a P/E ratio of 15.32 and a beta of 0.92. CVS Health Corporation has a 1-year low of $69.30 and a 1-year high of $88.92.

CVS Health Corporation (NYSE:CVS) last released its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The firm had revenue of $45.69 billion during the quarter, compared to analyst estimates of $45.36 billion. During the same quarter in the prior year, the firm earned $1.32 EPS. The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. Equities analysts anticipate that CVS Health Corporation will post $5.88 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 3rd. Stockholders of record on Tuesday, October 24th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.60%. The ex-dividend date of this dividend is Monday, October 23rd. CVS Health Corporation’s payout ratio is currently 39.92%.

COPYRIGHT VIOLATION NOTICE: This article was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another publication, it was stolen and reposted in violation of US and international copyright law. The original version of this article can be viewed at https://www.watchlistnews.com/weybosset-research-management-llc-has-321000-holdings-in-cvs-health-corporation-cvs/1614274.html.

CVS has been the subject of several analyst reports. BidaskClub downgraded shares of CVS Health Corporation from a “hold” rating to a “sell” rating in a report on Friday, August 25th. Loop Capital initiated coverage on shares of CVS Health Corporation in a report on Thursday, August 24th. They issued a “hold” rating and a $83.00 target price for the company. Guggenheim reiterated a “buy” rating on shares of CVS Health Corporation in a report on Monday, July 3rd. Leerink Swann set a $90.00 target price on shares of CVS Health Corporation and gave the company a “buy” rating in a report on Tuesday, June 27th. Finally, Vetr downgraded shares of CVS Health Corporation from a “strong-buy” rating to a “buy” rating and set a $88.97 target price for the company. in a report on Monday, June 12th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $89.56.

In other news, Director Richard J. Swift sold 2,500 shares of the company’s stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $79.62, for a total transaction of $199,050.00. Following the completion of the sale, the director now owns 3,258 shares of the company’s stock, valued at approximately $259,401.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Thomas M. Moriarty sold 90,267 shares of the company’s stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $79.61, for a total transaction of $7,186,155.87. Following the sale, the executive vice president now directly owns 70,102 shares of the company’s stock, valued at approximately $5,580,820.22. The disclosure for this sale can be found here. Insiders have sold a total of 716,625 shares of company stock valued at $58,318,431 in the last ninety days. Insiders own 0.61% of the company’s stock.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.